Nikunj Solanki

Nikunj Solanki

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
AYAnup Lal Yadav
Anup Lal Yadav
SSSonal Solanki
Sonal Solanki
NSNikunj Solanki
Nikunj Solanki
VPVishin Ashish Patil
Vishin Ashish Patil
SSSreenath Sriram
Sreenath Sriram
JPJayashree Prasad
Jayashree Prasad
A decision-centric workflow was developed to link a QbD-defined design space with interpretable surrogate modeling for rapid selection of ultrasound-triggered doxorubicin-loaded chitosan microbubbles. A 15-run Box–Behnken design spanning chitosan, palmitic acid, and Pluronic F68 was used to quantify three critical quality attributes (CQAs)—mean size, encapsulation efficiency (EE), and burst release at 40 s (Burst40)—and to train response-specific surrogates evaluated by leave-one-out cross-validation (LOOCV). The DoE produced a broad performance envelope (size 2.35–4.85 µm; EE 60–82%; Burst40 55.6–95%) with clear composition-driven trade-offs, notably between EE and acoustic responsiveness. A regularized polynomial surrogate (PolyRidge) provided strong LOOCV performance for size (R²=0.885; RMSE = 0.264 µm) and EE (R²=0.871; RMSE = 2.18%), whereas Burst40 was only moderately predictable (R²=0.501; RMSE = 8.61%), consistent with threshold-like cavitation and microstructure sensitivity. Digital screening with multi-objective desirability and explainability (SHAP, permutation importance, partial dependence, LIME) shortlisted manufacturable candidates; experimental validation showed QbD/RSM was better calibrated for absolute size and EE, while both modeling approaches remained similarly limited for Burst40. Importantly, shortlisted formulations preserved suppressed baseline release and pronounced ultrasound-enhanced release, yielding trigger-dependent cytotoxicity and increased apoptotic commitment in MCF-7 cells.

23 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
SSSonal Solanki
Sonal Solanki
GKGarima Kumari
Garima Kumari
NSNikunj Solanki
Nikunj Solanki
DJDiksha Jindal
Diksha Jindal
GKG Usha Kiranmai
G Usha Kiranmai
ADAshok Dalimbe
Ashok Dalimbe
Background Voriconazole formulation development is often constrained by limited aqueous solubility and variable dissolution behavior. β-Cyclodextrin (β-CD) inclusion complexation prepared by solvent-free co-grinding is a practical solubility-enhancement strategy. A recent Quality-by-Design (QbD) study optimised this system using a central composite design (CCD); however, polynomial response surfaces can be difficult to interpret locally across the design space. Objective To perform an explainable artificial intelligence (XAI) secondary reanalysis of a published QbD CCD dataset for voriconazole–β-CD inclusion complexes, generating interpretable Random Forest (RF) surrogates for design-space understanding and comparing model behavior against published QbD checkpoints. Methods Factor–response data (13 CCD runs) were extracted exactly as reported for β-CD amount (A, mg) and grinding time (B, min) with responses solubility (Y1, mg/mL) and cumulative drug release (Y2, %CDR). Two RF regression surrogates (RF–Y1 and RF–Y2) were trained and evaluated by leave-one-out cross-validation (LOOCV). Published checkpoints were used for benchmarking against QbD predictions. Explainability was implemented using TreeSHAP, permutation feature importance (PFI), partial dependence/ICE plots, and LIME. RF-based response surfaces and a multi-response desirability map were generated to identify high-performance regions. Results LOOCV indicated modest predictive performance (Y1: R²=0.1629, MAE = 11.2217, RMSE = 14.4720; Y2: R²=0.2208, MAE = 12.3883, RMSE = 15.5143). RF design-space mapping indicated increasing Y1 and Y2 with higher A and B, with a broad high-response region. The RF desirability optimum occurred at A = 544.99 mg and B = 26.84 min with predicted Y1 = 66.09 mg/mL, Y2 = 89.08%, and desirability = 0.887. At the published high-performance checkpoint (A = 600 mg, B = 30 min), RF predictions closely matched the experimental results (Y1 ≈ 66.09 vs 65.86 mg/mL; Y2 ≈ 89.08 vs 85.93%), whereas the QbD polynomial overpredicted, especially for Y2. SHAP global importance suggested A dominated Y1 (mean |SHAP|: A = 7.37; B = 3.78), while Y2 depended on both factors (A = 7.48; B = 7.82); PFI supported strong influence of A (ΔMAE: Y1 A ≈ 11.03, B ≈ 5.42; Y2 A ≈ 12.31, B ≈ 5.97). Conclusion Explainable ML did not replace QbD; it augmented a published QbD dataset with transparent, multi-view interpretability and an alternative design-space depiction. RF + XAI triangulated factor priority (carrier-driven solubility; joint carrier–process control of release), highlighted plateau-like high-performance regions, and provided calibration-friendly predictions at the optimised condition. This workflow offers a practical template for integrating explainable AI into formulation-oriented QbD analyses.

1 June 2026 in Research Square
Verified
Preprint
Open access
PDF file
RDRahul Dhaigude
Rahul Dhaigude
SSSonal Solanki
Sonal Solanki
NSNikunj Solanki
Nikunj Solanki
STSreekanth Thota
Sreekanth Thota
PSPranita Santosh Shankaratti
Pranita Santosh Shankaratti
PCPallavi Chiprikar
Pallavi Chiprikar
Quality by Design (QbD) studies generate structured formulation datasets, but response surface models may not fully describe nonlinear or response-specific behavior in nanoparticle systems. This study reanalyzed a published silymarin-loaded lecithin/chitosan nanoparticle QbD dataset to determine whether independent explainable machine learning could add predictive and interpretive value to conventional QbD outputs. Twenty-nine formulation runs, comprising six formulation/process inputs and three critical quality attributes—particle size, polydispersity index (PDI), and entrapment efficiency—were extracted and modeled. A model-zoo of 105 regression variants per response was evaluated using leave-one-out cross-validation, followed by optimized-checkpoint comparison with reported QbD/RSM predictions, permutation feature importance, partial dependence analysis, and predictive design space mapping. Model performance was response dependent: XGBoost provided the best global particle-size prediction (R² = 0.926; RMSE = 27.52 nm), Extra Trees was best for PDI (R² = 0.695; RMSE = 0.0379), and distance-weighted KNN was best for entrapment efficiency (R² = 0.938; RMSE = 1.72%). At the optimized checkpoint, Gaussian Process regression predicted particle size with lower error than RSM (0.789 vs. 8.804 nm), and checkpoint-compatible Random Forest predicted PDI more closely than RSM (0.0004 vs. 0.032 absolute error), whereas RSM remained slightly closer for entrapment efficiency. Explainable AI identified lecithin:chitosan ratio and drug amount as recurring formulation drivers, while the predicted acceptable region was concentrated within intermediate formulation ranges. These findings support explainable machine learning as a complementary layer for QbD-based nanoparticle development rather than as a replacement for response surface modeling.

14 May 2026 in Research Square
Verified
Preprint
Open access
PDF file
SASanju
Sanju
SYSuresh Yarlagadda
Suresh Yarlagadda
VKVinay Kumar
Vinay Kumar
SSSreenath Sriram
Sreenath Sriram
NANabeel Ahmad
Nabeel Ahmad
SMSaumya Mishra
Saumya Mishra
Metformin hydrochloride orally disintegrating tablets require an appropriate balance between mechanical strength and rapid disintegration, particularly because the drug is administered at a relatively high dose and has unfavorable taste characteristics. The present study applied machine learning to published D-optimal design data for metformin hydrochloride orally disintegrating tablets to evaluate whether formulation and process variables could predict powder-flow and tablet-performance responses. The dataset contained 30 experimental runs with four inputs: co-processed metformin hydrochloride ratio, co-processed excipient ratio, compression pressure, and excipient brand. Five responses were modeled separately: angle of repose, Hausner’s ratio, Carr’s index, hardness, and disintegration time. Polynomial Ridge Regression, Random Forest, Extra Trees, Gradient Boosting, Support Vector Regression, Gaussian Process Regression, and k-nearest neighbors were compared using leave-one-out cross-validation. Model performance was assessed using mean absolute error, root mean square error, and cross-validated R². Gaussian Process Regression was the best model for Hausner’s ratio, Carr’s index, hardness, and disintegration time, while Support Vector Regression performed best for angle of repose. Tablet hardness and disintegration time were predicted with the strongest performance, with R² values of 0.840 and 0.858, respectively. In contrast, angle of repose was weakly predicted, with an R² of 0.158. Permutation importance and partial dependence analysis indicated that compression pressure and excipient brand were the main contributors to tablet-level responses. The findings show that machine learning can support interpretation of D-optimal formulation data, especially for tablet-performance attributes, while predictions remain limited by dataset size and absence of new external validation.

2 June 2026 in Research Square
Verified
Preprint
Open access
RDRahul Dhaigude1
Rahul Dhaigude1
SSSonal Solanki
Sonal Solanki
NSNikunj Solanki
Nikunj Solanki
ARAditi Raval
Aditi Raval
ASAarti Sharma
Aarti Sharma
RURashmi Rathi Upadhyay
Rashmi Rathi Upadhyay
Daidzein-loaded hydroxyapatite nanoparticles are promising carrier systems for improving the formulation performance of poorly soluble bioactive compounds; however, their critical quality attributes may show nonlinear and response-specific behaviour that is not always fully captured by conventional response surface modelling. This study implemented a descriptor-guided model-zoo learning framework to reanalyse a 17-run Quality by Design dataset of daidzein-loaded hydroxyapatite nanoparticles. Sixteen formulation-derived descriptors were generated from hydroxyapatite-to-daidzein ratio, dispersion volume and loading time, including quadratic, interaction, logarithmic, square-root and ratio-based terms. Descriptor-subset screening was then performed across multiple regression algorithms for response-wise prediction of particle size, entrapment efficiency and zeta potential. The reconstructed QbD/RSM model was most suitable for particle size, achieving internal leave-one-out cross-validation R² of 0.965 and RMSE of 0.725 nm. For entrapment efficiency, descriptor-guided Gaussian Process regression using loading time, squared carrier ratio and carrier-to-volume ratio improved prediction compared with QbD/RSM, giving LOOCV R² of 0.473. Descriptor Elastic Net using squared loading time, log-transformed dispersion volume, squared carrier ratio and carrier-to-volume ratio was selected for zeta potential, achieving LOOCV R² of 0.381 and low optimized-checkpoint error. Explainable AI analysis using permutation importance, SHAP and LIME identified response-specific descriptor contributions, while Lasso-based surrogate equations and symbolic regression provided interpretable equation-based approximations. These findings show that descriptor-guided model-zoo learning can extract additional predictive and interpretative value from small QbD formulation datasets while preserving formulation relevance and response-wise interpretability.

16 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
SSSonal Solanki
Sonal Solanki
STSreekanth Thota
Sreekanth Thota
NSNikunj Solanki
Nikunj Solanki
MPMahesh Kumar Posa
Mahesh Kumar Posa
SAShama Aphale
Shama Aphale
KLKulbhusan Lalwani
Kulbhusan Lalwani
Ultrasound-responsive microbubbles provide a powerful means for externally regulated drug delivery, yet their translation is often constrained by empirical formulation approaches and limited therapeutic selectivity. In this study, a Quality by Design (QbD) strategy was implemented to rationally engineer doxorubicin-loaded chitosan microbubbles with predictable physicochemical and biological performance. A Box–Behnken experimental design enabled systematic optimization of critical formulation variables, yielding a statistically validated design space governing microbubble size (≈ 3.2 µm), encapsulation efficiency (≈ 70–75%), and ultrasound-triggered burst release (> 80% within 40 s). The optimized formulation demonstrated minimal baseline drug leakage under non-activated conditions, while brief ultrasound exposure induced rapid, on-demand release. In vitro evaluation revealed a marked enhancement of anticancer efficacy in MCF-7 breast cancer cells following ultrasound activation, with a dramatic reduction in IC₅₀ to 0.0013 µg/mL compared with free doxorubicin (0.62 µg/mL). In contrast, cardiotoxicity in H9c2 cardiomyoblast cells remained attenuated under non-triggered conditions (IC₅₀ ≈ 8.72 µg/mL), resulting in a > 10³-fold improvement in therapeutic selectivity upon ultrasound activation. Mechanistic analysis indicated that intact microbubbles restrict passive drug diffusion, whereas ultrasound-induced cavitation and transient membrane permeabilization enable efficient intracellular delivery at the target site. Overall, this work demonstrates that integrating QbD-driven formulation control with spatially confined ultrasound activation can substantially expand the therapeutic window of doxorubicin, offering a transferable framework for precision, stimulus-responsive drug delivery without chemical modification of the parent drug.